APA vs RGEN · P/E 7.2, $7.26B cap vs P/E 143, rev $204.1M
APA Corporation (APA) versus Repligen Corporation (RGEN) — a side-by-side from cached financials, not a winner call.
APA Corporation (APA) is a oil & gas e&p company listed on US.
Repligen Corporation (RGEN) is a medical instruments & supplies company listed on NASDAQ.
APA does not have a complete income-statement cache yet.
Latest reported RGEN revenue for 2026-06-30 was $204.1M. Net income was $5.0M. Revenue was up 5.1% from 2026-03-31 to 2026-06-30. RGEN currently screens at market cap $7.43B and trailing P/E 143.1.
APA currently screens at market cap $7.26B and trailing P/E 7.2. RGEN currently screens at market cap $7.43B and trailing P/E 143.1.
Not investment advice. Open the APA and RGEN stock pages for the full models.
Not investment advice.